Role of dentate gyrus alterations in mesial temporal sclerosis

G Marucci1, G Rubboli, M Giulioni

  • 1Section of Pathology, Department of Hematology and Oncology of the University of Bologna, Bologna, Italy. gianluca.marucci@ausl.bologna.it

Clinical Neuropathology
|December 31, 2009
PubMed

Insights

Dentate gyrus alterations, specifically granule cell dispersion (GCD), are linked to better surgical outcomes in drug-resistant temporal lobe epilepsy (TLE) patients with mesial temporal sclerosis (MTS). This suggests GCD may improve seizure relief post-surgery.

Area of Science:

  • Neurology
  • Epileptology
  • Surgical Pathology

Background:

  • Drug-resistant chronic temporal lobe epilepsy (TLE) is a common indication for epilepsy surgery.
  • Mesial temporal sclerosis (MTS) is the most frequent pathology in surgically treated TLE.
  • The role of dentate gyrus alterations in TLE pathogenesis and surgical outcomes remains under investigation.

Purpose of the Study:

  • To investigate the association between dentate gyrus alterations, specifically granule cell dispersion (GCD), and surgical outcomes in patients with mesial temporal sclerosis (MTS).
  • To determine if GCD correlates with seizure frequency and postsurgical seizure relief in drug-resistant TLE.

Main Methods:

  • Retrospective analysis of 14 patients who underwent epilepsy surgery for MTS alone.
  • Histopathological examination for the presence of granule cell dispersion (GCD).
  • Correlation analysis between GCD, mean seizures per month, and Engel class (seizure relief outcome).

Main Results:

  • Granule cell dispersion (GCD) was identified in 50% of the studied MTS patients.
  • A statistically significant correlation was found between GCD and a lower mean number of seizures per month.
  • Patients with GCD had a significantly higher rate of seizure relief (Engel class 1A) post-surgery (85.71%) compared to those without GCD (42.86%).

Conclusions:

  • Dentate gyrus alterations, evidenced by GCD, are associated with a more favorable postsurgical outcome in patients with mesial temporal sclerosis (MTS).
  • GCD may serve as a potential biomarker for predicting seizure relief after epilepsy surgery in drug-resistant TLE.
  • These findings highlight the role of dentate gyrus pathology in the epileptogenesis of TLE.